Maria Cristancho, MD
Interventional Pain Medicine · Pompano Beach, FLNPI 1487064754
Payments from drug & device makers
Across 82 payments — averaging $84.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$1K
- Stimwave Technologies Incorporated$821
- Boston Scientific$500
- SPR Therapeutics, Inc$292
- Nevro Corp.$246
- plus $574 from 10 others
What the payments were for
- Grants$2,50036%
- Travel & lodging$1,77926%
- Food & beverage$2,68139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $3,087 |
| Abbott | 20 | $1,442 |
| Stimwave Technologies Incorporated | 6 | $821 |
| Boston Scientific | 8 | $500 |
| SPR Therapeutics, Inc | 3 | $292 |
| Nevro Corp. | 7 | $246 |
| Teva Pharmaceuticals USA, Inc. | 3 | $153 |
| Scilex Pharmaceuticals Inc. | 6 | $102 |
| Biohaven Pharmaceuticals, Inc. | 2 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Nalu Medical, Inc. | 1 | $35 |
| Saluda Medical Americas, Inc. | 2 | $27 |
| Curonix LLC | 1 | $21 |
| GRT US Holding, Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 2 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$2,500
- PROCLAIM$684
- StimQ Receiver Stimulator Kit Channel A US w Receiver$467
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$467
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$467
- Freedom 4A Receiver Kit Channel A US w Receiver$467
- Freedom 8A Receiver Kit Channel A US w Receiver$467
- INTELLIS ADAPTIVESTIM$446
- CFNS StimQ Peripheral Nerve StimulatorSystem$189
- SCS FreedonSpinal Cord Stimulator$189
- SPRINT PNS System$184
- Senza Spinal Cord Stimulation System$144
- GENERAL PAIN MANAGEMENT$135
- AJOVY$125
- Intracept$123
- SPECTRA WAVEWRITER$118
- ETERNA$101
How this compares
$6,961 in reported general payments places this provider in the 60th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 14 | $13,864 |
| Celecoxib | 95 | $1,872 |
| Tizanidine Hcl | 12 | $1,840 |
| Lidocaine | 20 | $1,557 |
| Pregabalin | 52 | $1,278 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $1,002 |
| Gabapentin | 71 | $704 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $701 |
| Duloxetine Hcl | 42 | $672 |
| Tramadol Hcl | 28 | $171 |
| Meloxicam | 20 | $30 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Pompano Beach
- Ajay AntonyGainesville$1.9M
- Louis RasoJupiter$1.6M
- Gilbert MbeoOrlando$1.4M
- George BesongOrange City$1.2M
- Gary KaoMiddleburg$1.1M
- Neil EllisTampa$1.1M
- Alexis RentaBoynton Beach$1.1M
- Michael EspositoVero Beach$1M
- Jose RiveraTampa$993K
- Nomen AzeemRiverview$691K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.